Rare diseases
Investigational molecules
Locations
Back to Spain444 clinical trials in Murcia, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
SpainSpainOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
SpainStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
SpainA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
SpainStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
SpainStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
SpainStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
SpainStudy on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients
SpainStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
SpainStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
SpainStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hematologic malignancies, including studies of new therapeutic combinations for chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. Research aims to evaluate novel treatment approaches and improve patient outcomes.
Comprehensive studies evaluating treatments for various solid tumors, including innovative approaches for breast cancer, melanoma, and gastric cancer. Research focuses on targeted therapies and immunotherapy combinations.
Groundbreaking research in neurological disorders, particularly focusing on multiple sclerosis and acute cerebral ischemic stroke. Studies aim to evaluate new therapeutic agents and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
